122 related articles for article (PubMed ID: 15059326)
21. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.
Quiñones LA; Irarrázabal CE; Rojas CR; Orellana CE; Acevedo C; Huidobro C; Varela NE; Cáceres DD
Asian J Androl; 2006 May; 8(3):349-55. PubMed ID: 16625286
[TBL] [Abstract][Full Text] [Related]
22. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea.
Lee KM; Kang D; Lee SJ; Park SK; Lee KH; Choi JY; Kim SU; Choi H; Choi SH; Kim YW; Hong YC; Cho SH
Oncol Rep; 2006 Nov; 16(5):1035-9. PubMed ID: 17016589
[TBL] [Abstract][Full Text] [Related]
23. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
24. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
25. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas.
Inoue H; Kiyohara C; Marugame T; Shinomiya S; Tsuji E; Handa K; Hayabuchi H; Onuma K; Hamada H; Koga H; Kono S
Cancer Res; 2000 Jul; 60(14):3749-52. PubMed ID: 10919645
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population.
Silig Y; Pinarbasi H; Günes S; Ayan S; Bagci H; Cetinkaya O
Cancer Invest; 2006 Feb; 24(1):41-5. PubMed ID: 16466991
[TBL] [Abstract][Full Text] [Related]
27. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
[TBL] [Abstract][Full Text] [Related]
28. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
29. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
30. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
31. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
Yang M; Choi Y; Hwangbo B; Lee JS
Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
[TBL] [Abstract][Full Text] [Related]
32. Smoking habit and genetic factors associated with lung cancer in a population highly exposed to arsenic.
Adonis M; Martínez V; Marín P; Berrios D; Gil L
Toxicol Lett; 2005 Oct; 159(1):32-7. PubMed ID: 16099114
[TBL] [Abstract][Full Text] [Related]
33. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
34. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina.
Moore LE; Wiencke JK; Bates MN; Zheng S; Rey OA; Smith AH
Cancer Lett; 2004 Aug; 211(2):199-207. PubMed ID: 15219943
[TBL] [Abstract][Full Text] [Related]
35. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
Guan TY; Li M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk.
Tamer L; Ateş NA; Ateş C; Ercan B; Elipek T; Yildirim H; Camdeviren H; Atik U; Aydin S
Cell Biochem Funct; 2005; 23(4):267-72. PubMed ID: 15473001
[TBL] [Abstract][Full Text] [Related]
38. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.
Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS
Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763
[TBL] [Abstract][Full Text] [Related]
39. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
40. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
